|
|
Home > Investor Relations >
Financials >
Balance Sheet > Ranbaxy Laboratories Limited - Consolidated (US GAAP) |
| |
Balance
Sheet
Untitled Document
| CONSOLIDATED
BALANCE SHEET
(All amounts in Rupees Million, unless otherwise stated) |
| |
As
at December 31, |
| 2006 |
2005 |
| ASSETS |
|
|
| Current
assets |
|
|
| Cash and cash equivalents |
2,762.81 |
2,286.33 |
| Restricted
cash |
108.18 |
64.79 |
| Accounts receivable, net of
allowances |
15,599.43 |
11,237.96 |
| Inventories |
15,992.42 |
13,539.97 |
| Deferred income taxes |
1,091.14 |
1,806.51 |
| Income taxes
recoverable |
1,757.31 |
1,608.02 |
| Other current assets, net
of allowances |
3,619.99 |
3,416.30
|
| Total
current assets |
40,931.28 |
33,959.88 |
| Property, plant and equipment,
net |
19,698.91 |
17,325.11 |
| Deferred income taxes |
1,792.04 |
1,753.44 |
| Investment securities |
600.24 |
423.21 |
| Goodwill, net |
10,262.79 |
4,379.95 |
| Intangible assets, net |
7,852.11 |
1,334.19 |
| Other assets |
1,042.63 |
670.96 |
| Total assets |
82,180.00 |
59,846.74 |
| LIABILITIES AND STOCKHOLDERS’
EQUITY |
|
|
| Current liabilities |
|
|
| Borrowings from banks and
financial institutions |
13,600.74 |
13,748.02 |
| Current portion of long term
debt |
3,490.11 |
3,142.86 |
| Trade accounts payable |
7,889.38 |
7,357.27 |
| Income taxes payable |
830.59 |
765.14 |
| Accrued expenses |
2,159.19 |
2,085.65 |
| Other current liabilities |
1,285.30 |
1,346.42 |
| Total Current Liabilities |
29,255.31 |
28,445.36 |
| Long-term debt, excluding
current portion |
22,432.96 |
3,116.74 |
| Deferred income taxes |
1,697.08 |
1,600.33 |
| Deferred revenue |
159.48 |
138.96 |
| Other liabilities |
1,848.35 |
958.71 |
| Total Liabilities |
55,393.18 |
34,260.10 |
| Minority interest |
334.28 |
164.72 |
| Commitments and contingencies
(See Note K, L,S and V) |
|
|
| Stockholders' equity |
|
|
| Common stock, Rs. 5.00 par
value, |
|
|
| 598,000,000 equity shares
authorized, |
|
|
| 372,686,964 and 372,442,190
equity shares |
|
|
| issued and outstanding at December 31,
2006 and 2005 respectively |
1,863.43 |
1,862.21 |
| Additional paid in capital |
6,735.13 |
6,388.29 |
| Deferred stock-based compensation |
– |
(73.93) |
| Retained earnings |
17,486.04 |
17,036.85 |
| Accumulated other comprehensive (loss)
/ income |
367.94 |
208.50 |
| Total stockholders’ equity |
26,452.54 |
25,421.92 |
| Total liabilities and stockholders’
equity |
82,180.00 |
59,846.74 |
| The accompanying notes are
an integral part of these consolidated financial statements. |
|
|
|